SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-17-000007
Filing Date
2017-08-09
Accepted
2017-08-09 16:42:04
Documents
69
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q2x2017.htm 10-Q 970648
2 EXHIBIT 31.1 exhibit311q22017.htm EX-31.1 9698
3 EXHIBIT 31.2 exhibit312q22017.htm EX-31.2 9661
4 EXHIBIT 32.1 exhibit321q22017.htm EX-32.1 10012
  Complete submission text file 0000827871-17-000007.txt   5689198

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT egrx-20170630.xml EX-101.INS 1054971
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20170630.xsd EX-101.SCH 40855
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20170630_cal.xml EX-101.CAL 90352
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20170630_def.xml EX-101.DEF 232961
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20170630_lab.xml EX-101.LAB 575743
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20170630_pre.xml EX-101.PRE 379836
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 171018492
SIC: 2834 Pharmaceutical Preparations